文献速递浆细胞疾病

SORT1/LAMP2介导的细胞外囊泡分泌与细胞黏附与多发性骨髓瘤来那度胺耐药相关

SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma.
PubMed 文献 · Blood Adv · 2022-01-01

该研究比较来那度胺耐药与亲本多发性骨髓瘤(MM)细胞系,发现耐药细胞细胞外囊泡(EV)分泌和黏附能力显著升高;全转录组分析显示SORT1和LAMP2是EV分泌关键调控基因,沉默后耐药细胞EV分泌减少、细胞黏附丧失、对来那度胺敏感性增加;公共转录组数据证实EV分泌和细胞黏附相关基因与患者预后相关。

要点

  • 耐药MM细胞系EV分泌和黏附能力较亲本细胞系显著升高。
  • SORT1和LAMP2是EV分泌关键调控基因,沉默可逆转耐药细胞黏附并增加来那度胺敏感性。
  • 公共转录组数据证实EV分泌和细胞黏附相关基因与MM患者预后相关。

核心结论

  • 研究揭示由SORT1和LAMP2介导的EV分泌和细胞黏附是MM来那度胺耐药的新机制。

研究设计与样本

  • 研究比较来那度胺耐药细胞系与亲本细胞系,并进行全转录组分析和公共转录组数据分析。

主要发现

  • 耐药细胞系较亲本细胞系EV分泌和黏附能力显著升高。
  • 全转录组分析显示SORT1和LAMP2是EV分泌的关键调控基因。
  • 沉默SORT1和LAMP2导致耐药细胞EV分泌减少和细胞黏附丧失,并增加对来那度胺的敏感性。
  • 公共转录组数据证实EV分泌和细胞黏附相关基因与患者预后相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) is a hematopoietic malignancy whose prognosis has improved with the development of new agents such as lenalidomide over the last decade. However, long-term exposure to drugs induces the acquisition of resistance by MM cells and leads to treatment failure and poor prognosis. Here, we show the molecular and cellular mechanisms of lenalidomide resistance in MM. In a comparison between lenalidomide-resistant cell lines and the parental cell lines, extracellular vesicle (EV) secretion and adherence abilities were significantly elevated in the resistant cells. Whole-transcriptome analysis revealed that the SORT1 and LAMP2 genes were key regulators of EV secretion. Silencing of these genes caused decreased EV secretion and loss of cell adhesion in the resistant cells, resulting in increased sensitivity to lenalidomide. Analysis of publicly available transcriptome data confirmed the relationship between genes related to EV secretion and cell adhesion and patient prognosis. Together, our findings reveal a novel mechanism of lenalidomide resistance in MM mediated by EV secretion and cell adhesion via SORT1 and LAMP2.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Yamamoto T, Nakayama J, Yamamoto Y, et al. SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma. Blood Adv. 2022. PMID: 34979567. doi:10.1182/bloodadvances.2021005772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。